COMPASS Pathways (CMPS) News Today $4.81 +0.09 (+1.91%) Closing price 04:00 PM EasternExtended Trading$4.80 -0.01 (-0.21%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMPS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Compass Pathfinder Limited: Compass Pathways to Participate in Four Investor Conferences in SeptemberAugust 27 at 8:55 AM | finanznachrichten.deCompass Pathways to Participate in Four Investor Conferences in SeptemberAugust 27 at 6:30 AM | businesswire.com22NW LP Makes New $1.85 Million Investment in COMPASS Pathways PLC Sponsored ADR $CMPSAugust 26 at 7:23 AM | marketbeat.comCompass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Depression TreatmentAugust 22, 2025 | msn.comCompass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Treatment-resistant DepressionAugust 20, 2025 | msn.comCOMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Stock Position Increased by Aisling Capital Management LPAugust 16, 2025 | marketbeat.comCOMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Shares Bought by Vivo Capital LLCAugust 9, 2025 | marketbeat.comHC Wainwright Cuts Earnings Estimates for COMPASS PathwaysAugust 8, 2025 | marketbeat.comCompass Pathways price target lowered to $40 from $45 at H.C. WainwrightAugust 6, 2025 | finance.yahoo.comCOMPASS Pathways (NASDAQ:CMPS) Given New $40.00 Price Target at HC WainwrightAugust 5, 2025 | marketbeat.comCOMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Stake Lifted by BIT Capital GmbHAugust 4, 2025 | marketbeat.comCompass Pathways: Overly Confident Management Or Overly Skeptical MarketAugust 3, 2025 | seekingalpha.comCOMPASS Pathways (NASDAQ:CMPS) Releases Earnings Results, Misses Estimates By $0.01 EPSAugust 3, 2025 | marketbeat.comCOMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of "Moderate Buy" from BrokeragesAugust 3, 2025 | marketbeat.comCanaccord Genuity Group Reaffirms Buy Rating for COMPASS Pathways (NASDAQ:CMPS)August 2, 2025 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | msn.comCompass (CMPS) Q2 Loss Improves 27%August 1, 2025 | fool.comCompass Pathways Announces Second Quarter 2025 Financial Results and Business HighlightsJuly 31, 2025 | businesswire.comCompass Pathways Appoints Justin Gover to Board of DirectorsJuly 29, 2025 | businesswire.comCOMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Shares Bought by ARK Investment Management LLCJuly 27, 2025 | marketbeat.comCOMPASS Pathways (CMPS) Projected to Post Quarterly Earnings on ThursdayJuly 24, 2025 | marketbeat.comThese 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?July 20, 2025 | fool.comHC Wainwright Expects Reduced Earnings for COMPASS PathwaysJuly 17, 2025 | marketbeat.comQ1 Earnings Estimate for CMPS Issued By HC WainwrightJuly 16, 2025 | marketbeat.comCathie Wood’s ARK Adds 125K COMPASS Pathways plc (CMPS) SharesJuly 15, 2025 | msn.comCOMPASS Pathways' (CMPS) Buy Rating Reiterated at HC WainwrightJuly 15, 2025 | marketbeat.comCOMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - Yahoo FinanceJuly 10, 2025 | finance.yahoo.comCompass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ETJuly 10, 2025 | businesswire.comCOMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 8, 2025 | marketbeat.comCOMPASS Pathways PLC ADR Advanced Charts | CMPS - Barron'sJuly 6, 2025 | barrons.comCathie Wood’s ARK adjusts with Beam, Compass, and Komatsu tradesJuly 4, 2025 | investing.comCOMPASS Pathways PLC ADR Financials | CMPS | Barron'sJuly 3, 2025 | barrons.comThis Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip?June 29, 2025 | msn.comCompass’ stock slips despite psilocybin trial hitting targetJune 25, 2025 | msn.comCompass Pathways: Psychedelics Drug Data Sends Share Price South - Rating DowngradeJune 25, 2025 | seekingalpha.comCompass shares hits record low after depression drug fails to impressJune 24, 2025 | msn.comEvercore ISI Group Downgrades COMPASS Pathways plc - Depositary Receipt () (CMPS)June 24, 2025 | msn.comCompass plummets as late-stage data on psychedelic asset for depression disappointsJune 23, 2025 | msn.comCompass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ AnalystsJune 23, 2025 | msn.comCompass Pathways' late-stage psilocybin trial targeting treatment-resistant depression meets primary endpointJune 23, 2025 | proactiveinvestors.comCompass Pathways stock plunges after Phase 3 trial resultsJune 23, 2025 | za.investing.comStock Traders Purchase Large Volume of Call Options on COMPASS Pathways (NASDAQ:CMPS)June 23, 2025 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Cut to In-Line at Evercore ISIJune 23, 2025 | marketbeat.comVizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market SessionJune 23, 2025 | benzinga.comCompass Pathways' depression drug succeeds late-stage trialJune 23, 2025 | reuters.comCompass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant DepressionJune 23, 2025 | businesswire.comCOMPASS Pathways plc (NASDAQ:CMPS) Given Consensus Rating of "Buy" by AnalystsJune 13, 2025 | marketbeat.comCantor Fitzgerald Analysts Raise Earnings Estimates for CMPSMay 31, 2025 | marketbeat.comCOMPASS Pathways' (CMPS) "Overweight" Rating Reiterated at Cantor FitzgeraldMay 28, 2025 | marketbeat.comMillennium Management LLC Decreases Stake in COMPASS Pathways plc (NASDAQ:CMPS)May 26, 2025 | marketbeat.com Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMPS Media Mentions By Week CMPS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPS News Sentiment▼0.430.99▲Average Medical News Sentiment CMPS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPS Articles This Week▼53▲CMPS Articles Average Week Get the Latest News and Ratings for CMPS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for COMPASS Pathways and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies APGE News Today BEAM News Today TWST News Today IMCR News Today CDTX News Today AUPH News Today BHVN News Today WVE News Today TVTX News Today TLRY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMPS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding COMPASS Pathways PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share COMPASS Pathways With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access